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Abstract 
Triclisinone (2), a new ochnaflavone derivative, was isolated from the aerial parts of Triclisia 
gilletii, along with known drypemolundein B (1) and eight other known compounds. The 
chemical shifts of drypemolundein B (1) have been partially revised based on reinterpretation 
of NMR spectroscopic data. The eight other secondary metabolites are composed of: (+)-
nonacosan-10-ol (3); stigmasterol (4), 3-O-ȕ-D-glucopyranosylsitosterol (5), 3-O-ȕ-D-
glucopyranosylstigmasterol (6); oleanic acid (7); myricetin (8), quercetin (9) and 3-
methoxyquercetin (10). Their structures were elucidated using IR, MS, NMR 1D and 2D, 1H 
and 13C and comparison with literature data. Furthermore, compounds 1, 2, 5, 6, 8, 9 and the 
crude extract were tested against Mycobacterium tuberculosis. Compounds 1, 2, 8 and 9 
displayed moderate to very good activity against resistant strain (codified AC 45) of M. 
tuberculosis with minimum inhibitory concentrations (MICs) ranged from 3.90 to 62.5 
μg/mL.  
Keywords: Triclisia gelletii; Menispermaceae; ochnaflavone derivative; NMR chemical shift 
analysis; antimycobacterial activity. 
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Experimental section (Annex) 
General procedures 
Melting points were uncorrected and were measured on a Mettler Toledo instrument. IR 
spectra were recorded on an Alpha FT-IR Spectrometer from Bruker, while 1D and 2D NMR 
spectra were obtained on a Bruker DRX 500 (500 MHz for 1H and 125 MHz for 13C spectra) 
spectrometer (Bruker, Rheinstetten, Germany) with chemical shifts reported in į (ppm) using 
TMS (įH) as an internal standard. The HR-ESI-MS were obtained on LTQ-FT instrument 
(Thermo Scientific). LC-MS were measured with Shimadzu LC-MS system using a Lícolumn 
2 ODS (I.D. 2.1 × 100 mm, Chemical Evaluation and Research Institute, Japan), at a flowrate 
of 0.2 mL miní1, a detection wavelength of 350 and 300 nm, and FMW (HCOOH/MeCN/H2O 
= 1:12:87) as eluent, ESI+ 4.5 kV, ESIí 3.5 kV, 250°C. Optical rotations were measured on a 
Perkin-Elmer 341 polarimeter. Silica gel 60 (230–400 mesh E. Merck, Darmstadt, Germany) 
and  Sephadex LH-20 were employed for column chromatography, the solvent mixing 
systems for elution were mainly CH2Cl2/MeOH for the phytochemical study with increasing 
polarity and pure MeOH, while precoated aluminium sheets silica gel 60 F254 were used for 
TLC. 
Extraction and isolation 
Dried and powered leaves of T. gilletii (109 g) were extracted for 48 h with MeOH (3 x 1L) at 
room temperature. After filtration and evaporation of the solvent, the crude MeOH extract (12 
g) was subjected to column chromatography CC (SiO2, eluting with a gradient solvent system 
(CH2Cl2/MeOH) giving four main fractions: I (2.4 g), II (1.6 g), III (3.8 g), IV (4.2 g). 
Fraction I (2.4 g) was submitted to a silica gel column using solvent system CH2Cl2/MeOH 
(60/1) to give three sub-fractions (Ia, Ib and Ic). Sub-fraction Ib (0.42 g) was subjected to a 
silica gel column (SiO2) using solvent system CH2Cl2/MeOH (60/1-40/1) in gradient elution 
to obtain compound 3 (6 mg). Sub-fraction Ic (0.38 g) was purified using silica gel column 
with gradient CH2Cl2/MeOH (40/1-30/1) to give compound 4 (9 mg). Fraction II was 
chromatographed as described above to afford three sub-fractions (IIa, IIb and IIc). Sub-
fraction IIa (0.28 g) was fractionated by silica gel column in gradient elution of 
CH2Cl2/MeOH (40/1-20/1) to obtain compounds 5 (16 mg) and 6 (7 mg). Compound 1 (13 
mg) was isolated from the sub-fraction IIb (0.49 g) using silica gel column with solvent 
system CH2Cl2/MeOH (40/1-30/1). Sub-fraction IIc (0.83 g) was fractionated and purified 
using silica gel column and eluted with solvent system CH2Cl2/MeOH (40/1-20/1) to afford 7
(2.8 mg).  Fraction III was submitted to a silica gel column as above eluted with solvent 
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system CH2Cl2/MeOH (20/1 to 5/1) to give five sub-fractions (IIIa, IIIb, IIIc, IIId and IIIe). 
Sub-fraction IIIc (0.74 g) was subjected to sephadex LH-20 column, eluted with MeOH to 
afford compounds 8 (11 mg) and 9 (4 mg). Sub-fraction IIId (0.42 g) was also purified via 
sephadex LH-20 to obtain compound 10 (4.8 mg). Fraction IV was subjected to a silica gel as 
described above and eluted with solvent system CH2Cl2/MeOH (20/1 to 5/1) to give four sub-
fractions (IVa, IVb, IVc and IVd). Sub-fraction IVc (0.89 g) was successively 
chromatographed using a silica gel column in gradient elution of CH2Cl2/MeOH (20/1-1/1) to 
obtain compound 2 (68 mg). 
Antitubercular activity 
For the present study, the mycobacteria (M. tuberculosis) used was a clinical isolated strain 
resistant to Isoniazid codifies as AC 45 (this strain was obtained from Sangmelima district’s 
Hospital in South Region of Cameroon). The genetical profile of the resistance has been 
carried out at Laboratory for Tuberculosis Research (Biotechnology Centre, University of 
Yaoundé I) through Line probe Assay method. The mycobacteria strain has been cultured at 
37 oC for two week in Middlebrook 7H9 (Himedia, India) supplemented with 0.05% (v/v), 
2% glycerol and 10% OADC (oleic acid-albumin-dextrose-catalase of Liofilchem s.r.l, Italia). 
The optical density of 0.45 to 0.55 was measured using spectrophotometer at 550 nm to obtain 
a suspension of 1.5 x108 UFC/mL (Collins et al. 1997). The activity of all phytochemicals 
(extract and pure compounds) against the aforementioned M. tuberculosis strains was tested 
using the microplate Alamar Blue assay as described previously by Collins et al. 1997 and 
Jiménez-Arellanes et al. 2003; 2007. In a 96 well microplates, all wells received 100 μL of 
supplemented Middlebrook 7H9 broth, then working metabolites solutions (100 μL) were 
poured into the first well of each row, from which two-fold dilution series were made through 
the microplate column. The test inoculum (100 μL) was added to all testing wells, as well as 
to the drug-free control wells. The final concentration of DMSO in wells was 7% v/v. The 
final concentrations tested ranged from 250 to 0. 244 μg/mL for pure compounds and 5000 to 
4,882 μg/mL for extracts. Rifampicin was used as standard drug. Each concentration was 
assayed in triplicate. Each microplate was sealed with parafilm paper and incubated for 14 
days at 37oC. After that, 40 μL of Alamar blue solution was added to two columns of each 
triplicate in other to show mycobacterial growth and the plate were re-incubated at 37oC for 
24 h. After one day of incubation, the Minimal Inhibitory Concentration (MIC) was defined 
as the lowest concentration of phytochemicals that inhibited the bacterial growth (prevents a 
color change from blue to pink) after incubation time (CLSI 2011). The Minimal Bactericidal 
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Concentration (MBC) determination, 50 ȝL of each wells which concentration were  MIC 
was sub-cultured in 150 ȝL of Mbk 7H9 medium and incubated at 37 ° C. for 10 days, then 
mycobacterial growth was carried out by addition of 40 ȝL of alamar blue. MBC was defined 
as the lowest concentration of extract at which no visible growth of the germ was observed 
(CLSI 2011). 
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Figure S1. Some characteristic NOESY correlations of compound 1 
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Figure S2. selected HMBC (ĺ) and NOESY ( ) correlations of compound 2
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Table S1: 1H and 13C-NMR spectroscopic dataa of compound 1 (500 and 125 MHz in CDCl3) 
į in ppm and drypemolundein B. (300 and 75 MHz in CDCl3) 
 Compound 1  drypemolundein B 
No. įC įH (J in Hz)  įC įH (J in Hz) 
1 22.4 t 1.99; 1.71 (m)  22.2 t - 
2 41.5 t 2.21 (-b)  40.8 t - 
3 207.8 s   212.1 s  
4 57.9 d 2.12 (m)  57.9 d - 
5 41.9 s   42.2 s  
6 37.6 t 1.70 (m); 1.30 (-b)  41.0 t - 
7 18.3 t 1.56 (m)  18.4 t - 
8 52.8 d 1.41 (m) (c)  53.0 d 2.38 (m) 
9 59.6 s (c)   55.5 s   
10 59.6 d (c) 1.40 (-b)  53.1 d - 
11 213.8 s   214.2 s  
12 41.6 t 2.23; 2.15 (m)  51.2 t 2.62; 2.01 (m, 11.4) 
13 38.3 s (c) -  44.0 s - 
14 39.5 s (c) -  43.8 s - 
15 31.2 t 1.30; 1.00 (m)  31.6 t - 
16 36.1 t 0.99 (-b)  36.1 t - 
17 29.9 s -  29.6 s - 
18 42.1 d 1.60 (-b)  36.4 d - 
19 38.4 t 1.80; 1.31 (m)  35.4 t - 
20 28.4 s -  28.3 s - 
21 32.8 t 0.99 (-b)  33.0 t - 
22 39.3 t -  38.9 t - 
23 6.8 q 0.88 (d, 6.4)  6.8 q 0.86 (d, 3.1) 
24 14.8 q 0.77 (s)  14.5 q 0.73 (s) 
25 18.1 q 0.87 (s)  18.1 q 0.90 (s) 
26 20.3 q 1.01 (s)  19.0 q 0.88 (s) 
27 18.6 q 1.02 (s)  19.8 q 1.39 (s) (d) 
28 31.3 q 1.18 (s)  31.8 q 0.91 (s) 
29 35.0 q (c) 0.96 (s)  31.7 q 1.04 (s) (d) 
30 31.6 q (c) 1.00 (s)  34.2 q 0.91 (s) 
a) Assignments were confirmed by DEPT-135, HSQC, HMBC, COSY and NOESY 
experiments. b) Overlapping signals. c) The assignments are different from those in Wandji et 
al. (2000). d) Mismatched chemical shift values beared by the same carbon atom (CH3-29). 
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Table S2: 1H and 13C-NMR spectroscopic dataa of compound 2 (500 and 125 MHz in DMSO-
d6) į in ppm 
Position įC įH (J in Hz)
1 / / 
2 164.4 s  
3 108.0 d 7.14 (s) 
4 182.2 s  
4a 104.7 s  
5 161.6 s  
6 98.9 d 6.16 (d, 2.0) 
7 164.5 s  
8 94.4 d 6.48 (d, 2.0) 
8a 160.6 s  
1ƍ 109.5 s  
2ƍ 155.0 s  
3ƍ 102.1 d 6.82 (s) 
4ƍ 157.3 s  
5ƍ 133.4 s  
6ƍ 122.3 d 7.79 (s) 
1ƍƍ / / 
2ƍƍ 164.4 s  
3ƍƍ 103.3 d 6.87 (s) 
4ƍƍ 182.1 s  
4aƍƍ 103.5 s  
5ƍƍ 161.5 s  
6ƍƍ 99.0 d 6.33 (d, 2.0) 
7ƍƍ 164.6 s  
8ƍƍ 93.9 d 6.53 (d, 2.0) 
8aƍƍ 160.6 s  
1ƍƍƍ 122.6 s  
2ƍƍƍ 129.0 d 7.96 (d, 8.6) 
3ƍƍƍ 116.2 d 6.90 (d, 8.6) 
4ƍƍƍ 157.6 s  
5ƍƍƍ 116.2 d 6.90 (d, 8.6) 
6ƍƍƍ 129.0 d 7.96 (d, 8.6) 
4ƍ-OCH3 56.2 q 3.78 (s) 
a) Assignments were confirmed by DEPT-135, HSQC, HMBC, COSY and NOESY 
experiments. 
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Table S3. MIC and MBC values of the methanol extract and the isolated compounds against 
Mycobacterium tuberculosis (AC 45) 
 
Plant species/Compounds MICa (μg/mL) MBCb (μg/mL) MBC/MIC 
T. gilletii 1250 5000 4 
1 3.90 15.62 4 
2 62.5 125 2 
5 62.5 125 2 
6 62.5 250 4 
8 7.81 31.25 4 
9 62.5 125 2 
RMP 0.97 7.81 8 
 
               aMinimum Inhibitory Concentration 
               bMinimum Bactericidal Concentration 
          RMP = Rifampicin 
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Figure S3. LC-MS spectrum of compound 1 
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Figure S4. 1H NMR spectrum of compound 1 
 
Figure S5. 13C NMR spectrum of compound 1 
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Figure S6. DEPT 135 spectrum of compound 1 
 
Figure S7. HSQC spectrum of compound 1 
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Figure S8. HMBC spectrum of compound 1
 
Figure S9. 1H-1H COSY spectrum of compound 1
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Figure S10. ESI-MS spectrum of compound 2 
 
 
Figure S11. IR spectrum of compound 2 
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Figure S12. 1H NMR of compound 2 
 
 
 
Figure S13. DEPT 135 of compound 2 
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Figure S14. 1H-1H spectrum of compound 2 
 
 
Figure S15. HSQC spectrum of compound 2 
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Figure S16. HMBC spectrum of compound 2 
 
 
Figure S17. NOESY spectrum of compound 2 
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Figure S18. Genotype profile of M. tuberculosis codifies AC 45. 
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